INTRALIPID 10% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Intralipid 10%, and when can generic versions of Intralipid 10% launch?
Intralipid 10% is a drug marketed by Fresenius and is included in one NDA.
The generic ingredient in INTRALIPID 10% is soybean oil. There are thirteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
Summary for INTRALIPID 10%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 83 |
Formulation / Manufacturing: | see details |
DailyMed Link: | INTRALIPID 10% at DailyMed |
Recent Clinical Trials for INTRALIPID 10%
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yale University | Phase 1 |
University of Kansas Medical Center | Early Phase 1 |
Assiut University | N/A |
Pharmacology for INTRALIPID 10%
Drug Class | Lipid Emulsion |
Anatomical Therapeutic Chemical (ATC) Classes for INTRALIPID 10%
US Patents and Regulatory Information for INTRALIPID 10%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius | INTRALIPID 10% | soybean oil | INJECTABLE;INJECTION | 017643-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |